首页> 外文期刊>European journal of neurology: the official journal of the European Federation of Neurological Societies >Thrombectomy outcomes for acute stroke patients with anterior circulation tandem lesions: a clinical registry and an update of a systematic review with meta‐analysis
【24h】

Thrombectomy outcomes for acute stroke patients with anterior circulation tandem lesions: a clinical registry and an update of a systematic review with meta‐analysis

机译:前循环串联病变的急性中风患者的血栓切除术后:临床登记处和通过META分析进行系统审查的更新

获取原文
获取原文并翻译 | 示例
           

摘要

Background and purpose Although mechanical thrombectomy ( MT ) appears to be superior in stroke patients with extracranial carotid disease ( ECD ) compared to thrombolysis alone, the impact of emergent carotid stenting during MT remains unclear. The MT outcomes were assessed in anterior stroke patients with ECD , especially when combined with carotid stenting. Methods A retrospective analysis of our registry was performed and an update of a systematic review and meta‐analysis of MT studies with or without stenting for anterior circulation stroke with ECD published between November 2010 and April 2017 was conducted. Results In our registry, 46 patients with ECD underwent MT . In the meta‐analysis including 13 primary studies plus our prospective registry data (590 patients in total), the successful reperfusion rate (modified thrombolysis in cerebral infarction score ≥2b) reached 75% [95% confidence interval ( CI ) 69%–81%]. The rate of symptomatic intracranial haemorrhage ( sICH ) was 8% (95% CI 6%–11%), 90‐day favourable outcome was achieved in 50% (95% CI 42%–59%) and mortality rate was 16% (95% CI 11%–22%). When using carotid stenting, rates of successful reperfusion, sICH , 90‐day favourable outcome and mortality were 80% (95% CI 73%–87%), 7% (95% CI 4%–12%), 53% (95% CI 43%–62%) and 14% (95% CI 9%–19%), respectively. Conclusions Our data report an association between acute stenting and successful reperfusion rates in stroke patients with tandem lesion treated with MT . Further studies are warranted to determine the intracranial bleeding risk after MT and stenting according to the antiplatelet therapy.
机译:背景和目的虽然机械血液切除术(MT)似乎在脑外颈动脉疾病(ECD)中似乎优越,但与单独溶栓相比,MT期间出苗的颈动脉队的影响尚不清楚。在前卒中患者的ECD中评估了MT结果,特别是与颈动脉支架结合时。方法对我们的登记处进行回顾性分析,并对2010年11月至2017年11月间发表的ECD进行了有或没有支撑的MT研究的系统审查和META分析的更新。结果我们的注册表,46名ECD患者接受了MT。在包括13个初级研究的META分析中加上我们的前瞻性注册数据(总共590名患者),成功的再灌注速率(脑梗塞分数≥2b的改性溶栓)达到75%[95%置信区间(CI)69%-81 %]。症状颅内出血(SICH)的速率为8%(95%CI 6%-11%),90天良好的结果在50%(95%CI 42%-59%)和死亡率为16%( 95%CI 11%-22%)。使用颈动脉支架时,成功再灌注率,SICH,90天有利的结果和死亡率为80%(95%CI 73%-87%),7%(95%CI 4%-12%),53%(95 %CI 43%-62%)分别和14%(95%CI 9%-19%)。结论我们的数据报告了用MT治疗的串联病变中卒中患者的急性支架和成功再灌注率之间的关联。需要进一步的研究以根据抗血小板疗法确定MT和支架后的颅内出血风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号